Everolimus Novartis 0,25 mg Tablett

Country: Sweden

Bahasa: Sweden

Sumber: Läkemedelsverket (Medical Products Agency)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
20-04-2018
Ciri produk Ciri produk (SPC)
20-04-2018

Bahan aktif:

everolimus

Boleh didapati daripada:

Novartis Sverige AB

Kod ATC:

L04AH02

INN (Nama Antarabangsa):

everolimus

Dos:

0,25 mg

Borang farmaseutikal:

Tablett

Komposisi:

everolimus 0,25 mg Aktiv substans; laktos (vattenfri) Hjälpämne; laktosmonohydrat Hjälpämne; butylhydroxitoluen Hjälpämne

Kelas:

Apotek

Jenis preskripsi:

Receptbelagt

Kawasan terapeutik:

Everolimus

Status kebenaran:

Avregistrerad

Tarikh kebenaran:

2003-08-08

Risalah maklumat

                                1
PACKAGE LEAFLET: INFORMATION FOR THE USER
EVEROLIMUS NOVARTIS 0.25 MG TABLETS
EVEROLIMUS NOVARTIS 0.5 MG TABLETS
EVEROLIMUS NOVARTIS 0.75 MG TABLETS
EVEROLIMUS NOVARTIS 1.0 MG TABLETS
Everolimus
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Everolimus Novartis is and what it is used for
2.
What you need to know before you take Everolimus Novartis
3.
How to take Everolimus Novartis
4.
Possible side effects
5.
How to store Everolimus Novartis
6.
Contents of the pack and other information
1.
WHAT EVEROLIMUS NOVARTIS IS AND WHAT IT IS USED FOR
The active substance of Everolimus Novartis is everolimus.
Everolimus belongs to a group of medicines called immunosuppressants.
It is used in adults to prevent
the body’s immune system from rejecting a transplanted kidney, heart
or liver.
Everolimus Novartis is used together with other medicines, such as
ciclosporin for kidney and heart
transplantation, tacrolimus for liver transplantation, and
corticosteroids.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE EVEROLIMUS NOVARTIS
DO NOT TAKE EVEROLIMUS NOVARTIS

if you are allergic (hypersensitive) to everolimus or any of the other
ingredients of this medicine
(listed in section 6).

if you are allergic (hypersensitive) to sirolimus.
IF ANY OF THE ABOVE APPLIES TO YOU, TELL YOUR DOCTOR AND DO NOT TAKE
EVEROLIMUS NOVARTIS.
WARNINGS AND PRECAUTIONS
TALK TO YOUR DOCTOR BEFORE TAKING EVEROLIMUS NOVARTIS:

Medicines that suppress the immune system like Everolimus Novartis
reduce your body´s
ability
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Inggeris 27-03-2015
Ciri produk Ciri produk Inggeris 27-03-2015